Triplet Therapeutics jobs and careers
Cambridge, MA, United States
About Triplet Therapeutics
Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- a group of more than 50 known genetic diseases including Huntington’s disease, myotonic dystrophy, spinocerebellar ataxias, fragile X syndrome, and familial amyotrophic lateral sclerosis (ALS) -- leveraging insights from patient genetics. Triplet designs and develops potential therapeutics for REDs using its proprietary thRED Engine, which enables the Company to develop a single oligonucleotide targeting the DNA Damage Response (DDR) pathway to potentially treat multiple REDs. Triplet is backed by investments from Atlas Venture, MPM Capital and Pfizer Ventures, along with Invus, Partners Innovation Fund and Alexandria Venture Investments.
Founded in 2019 by Nessan Bermingham.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $59M
- Headquarters
- Cambridge
Leadership
The top of Triplet Therapeutics's org chart, with how many people report into each leader.
Nessan Bermingham
Founder, President & CEO
15 reports
Alan J. Buckler
Chief Scientific Officer
6 reports
Irina Antonijevic
Chief Medical Officer
1 report
David Morrissey
SVP, Technology
1 report
Amy Lurier
SVP, Talent Acquisition & People
Eric Sullivan
Chief Financial Officer
Jeff Cerio
SVP, General Counsel
Amar Ghodasara
Director, Business Development & Strategy
Board
Douglas Kerr
Director
Jean-François Formela
Chair
Kathy Biberstein
Independent Director
Nikola Trbovic
Director
Stephen Webster
Independent Director
Shinichiro Fuse
Director
Jobs at Triplet Therapeutics
No open positions right now. Explore more companies on TheJobsMap.